COVID-19: Gastrointestinal and hepatic manifestations and implications for clinical trials

May 31, 2020

Recent experience has indicated that the COVID-19 virus often presents as digestive discomfort, including abdominal pain, nausea and vomiting. For ongoing clinical trials, there is a danger of incorrectly reporting these symptoms. In this article, Parexel expert Michelle Pietzak, MD reviews current findings and offers practical recommendations for sponsors.

Previous Article
COVID-19: Digestive symptoms of the novel virus and implications for clinical trials
COVID-19: Digestive symptoms of the novel virus and implications for clinical trials

As the entire healthcare ecosystem grapples with the COVID-19 virus, more evidence surfaces every day of ma...

Next Article
Coronavirus (COVID-19) Update: Daily Roundup May 29, 2020
Coronavirus (COVID-19) Update: Daily Roundup May 29, 2020

Coronavirus (COVID-19) Update: Daily Roundup